Search Results
145 results
Your search is now limited to «Bladder Cancer» expert search.
PR Newswire 01/22/2019 08:00
Vessi's technology focuses first on bladder cancer, but can hopefully address other bladder illnesses such as overactive bladder, providing a win-win solution for patients, physicians and the healthcare system.
More from PR Newswire:
Pharmaceutical Commerce 01/19/2019 18:34
January brings a surge to new patient assistance programs (PAPs) which are charitable functions (with substantial pharma industry funding) to provide copay and other assistance to needy patients. Among some of the more prominent charity efforts, the Good Days / […]. The post New PAP programs for HIV, migraine, bladder cancer and an enzyme deficiency appeared first on Pharmaceutical Commerce .
Immuno-Oncology News 01/18/2019 07:04
A new collaboration between GeneCentric Therapeutics and researchers at the University of North Carolina at Chapel Hill is aimed at further understanding bladder cancer patients’ responses to immunotherapies.
More from Immuno-Oncology News: 01/17/2019 03:20
Over time, the bladder becomes exposed to many of the toxic elements that we expose ourselves to, which can sometimes lead to cancer.
More from
Healio News 01/16/2019 12:00
Tobacco smoke inhalation appears to be the most common risk factor for bladder cancer, causing more than 50% of bladder cancer cases,” Luca Boeri, MD, urology resident in the division of experimental oncology at IRCCS Ospedale San Raffaele in Italy, and colleagues wrote.
More from Healio News:
Onclive 01/15/2019 15:35
Petros Grivas, MD, PhD For patients with locally advanced or metastatic bladder cancer who are cisplatin-ineligible, treatment options are limited, making clinical trials invaluable to further developments, explained Petros Grivas, MD, PhD.
More from Onclive: 01/12/2019 09:02
In patients with muscle-invasive bladder cancer, smoking cigarettes was associated with poor response to cisplatin-based chemotherapy, found new study published in BJU International.
More from
Targeted Oncology 01/11/2019 14:43
Clinical staging was determined mostly by pathologic findings on resection of the bladder tumor and was supplemented with radiographic images.
More from Targeted Oncology: 01/11/2019 09:21
Condition : Recurrent Bladder Cancer Intervention : Drug: FPA144 Sponsor : Five Prime Therapeutics, Inc. Available.
More from
Hyperprogression after anti-programmed cell death ligand-1 therapy in a patient with recurrent metastatic urothelial bladder carcinoma following first-line cisplatin-based chemotherapy: a case report Shiyu Mao,1,* Junfeng Zhang,1,* Yadong Guo,1,* Ziwei Zhang,1 Yuan Wu,2 Wentao Zhang,2 Longsheng Wang,1 Jiang Geng,1 Yang Yan,1 Xudong Yao1 1Department of Urology, Shanghai Tenth People’s Hospital, Tongji University, Shanghai 200072, PR China; 2Department of Urology, Shanghai Tenth People’s Hospital, Anhui Medical University, Hefei 230032, PR China *These authors contributed equally to this work Background: Immune checkpoint blockade targeting programmed cell death ligand-1 (PD-L1)/programmed death-1 (PD-1) signaling was approved recently for lo.
More from International Journal of COPD:
FeedNavigator 01/09/2019 02:12
Metformin has been shown to suppress bladder cancer cell proliferation and potentiate cancer cell apoptosis via the mechanistic target of rapamycin (mTOR) pathway [14, 15.
More from FeedNavigator: 01/09/2019 01:49
In a study of patients with muscle-invasive bladder cancer who had undergone radical cystectomy, cigarette smoking was linked with poor response to cisplatin-based chemotherapy.
More from

Therapeutic Areas

Clinical Trials and Phases

Business Issues

Companies - Public

Companies - Venture Funded

Financial Results

Global Markets

Global Risk Factors

Government Agencies

Job Titles

Legal and Regulatory

Cell Receptors


Diagnostics and Therapeutics


Drugs - Brand Names

Drugs - Generic



Health Care

Health and Wellness

Human Anatomy

Mechanisms of Action

Medical Devices



Strategic Scenarios



On this page, you see the results of the search you have run.  You may also view the following:

  •  Click on this drop-down menu on the right hand side of the page, to choose between the machine learning-produced Insights Reports, or the listing of concepts extracted from the results, in chart or list format. 

  •  View the number of search results returned for the search in each of your collections, and click on any of those numbers to view the entire listing of results from the chosen collection.

  •  Use the search adjustment drop-downs to change the scope, sorting, and presentation of your results.

  •  Show or hide the record’s caption (content description).

  •  Show actions that can be made with the search result record.

  •  Click on the Save button after running your search, to save it so that its results will be updated each time relevant new content is added to the designated collection. You may choose to be notified via search alerts.

Click here for more info on Search Results

Click here for more info on Machine Learning applications